A boxed warning for testosterone on major adverse cardiovascular events is out and a new blood pressure warning is in, the FDA announced late last week as part of a class-wide labeling update for all ...

Please provide your email address to receive an email when new articles are posted on . The FDA removed a warning about CV risk from testosterone product labels after a randomized trial showed no link ...

Testosterone blockers are used with estrogen to help transgender women reduce male traits. Aldactone is the most common testosterone blocker and can also treat high blood pressure. Finasteride is a ...